<bill session="111" type="s" number="701" updated="2023-01-11T13:19:41Z">
  <state datetime="2009-03-25">REFERRED</state>
  <status>
    <introduced datetime="2009-03-25"/>
  </status>
  <introduced datetime="2009-03-25"/>
  <titles>
    <title type="display">Medicare Patient IVIG Access Act of 2009</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to improve access of Medicare beneficiaries to intravenous immune globulins (IVIG).</title>
    <title type="short" as="introduced">Medicare Patient IVIG Access Act of 2009</title>
  </titles>
  <sponsor bioguide_id="K000148"/>
  <cosponsors>
    <cosponsor bioguide_id="A000360" joined="2009-03-25"/>
    <cosponsor bioguide_id="B001233" joined="2009-03-31"/>
    <cosponsor bioguide_id="B000953" joined="2009-03-25"/>
    <cosponsor bioguide_id="B001266" joined="2009-05-07"/>
    <cosponsor bioguide_id="C000141" joined="2010-05-13"/>
    <cosponsor bioguide_id="M001176" joined="2009-04-27"/>
    <cosponsor bioguide_id="R000122" joined="2009-05-05"/>
    <cosponsor bioguide_id="R000146" joined="2009-05-04"/>
    <cosponsor bioguide_id="R000307" joined="2009-04-30"/>
    <cosponsor bioguide_id="V000127" joined="2009-04-23"/>
    <cosponsor bioguide_id="W000802" joined="2009-03-25"/>
    <cosponsor bioguide_id="W000779" joined="2009-03-25"/>
  </cosponsors>
  <actions>
    <action datetime="2009-03-25">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2009-03-25">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S3792-3793"/>
    </action>
    <action datetime="2009-03-25" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="111" type="h" number="2002" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Drug therapy"/>
    <term name="Government studies and investigations"/>
    <term name="Health information and medical records"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Home and outpatient care"/>
    <term name="Immunology and vaccination"/>
    <term name="Medicare"/>
    <term name="Public contracts and procurement"/>
  </subjects>
  <amendments/>
  <summary date="2009-05-07T22:08:10Z" status="Introduced in Senate">Medicare Patient IVIG Access Act of 2009 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to direct the Secretary of Health and Human Services to collect data on the differences, if any, between: (1) payments to physicians for immune globulins using average sales price payment methodology; and (2) costs incurred by physicians for furnishing these products. Requires the Secretary also to review data on the access of eligible individuals to immune globulins.

Requires the Secretary, after completion of the review, to provide, if appropriate, an additional payment to such physicians for all items related to the furnishing of immune globulins as part of hospital outpatient services.

Provides for Medicare coverage of and payment for intravenous immune globulin (IVIG) administered in the home.

Allows the Secretary to contract for the collection of data on the practice of IVIG infusion.

Directs the Secretary to review data collected under such a contract as well as data submitted by members of the medical community related to the current infusion payment codes under part B (Supplementary Medical Insurance) of SSA title XVIII.

Requires the Secretary, upon completion of any data collection and review, to: (1) notify the appropriate Medicare administrative contractors regarding which existing infusion codes shall be used for purposes of part B IVIG reimbursement; or (2) report to Congress and the RBRUS Committee (RUC) on why an additional infusion payment code is necessary.

Extends the meaning of durable medical equipment to include disposable drug delivery systems, including elastomeric infusion pumps, for the treatment of colorectal cancer.</summary>
</bill>
